Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo
about
Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain networkIs cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A 18F-FDG PET/CT study.APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.False positives in neuroimaging genetics using voxel-based morphometry data.Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's diseaseSex and age differences in atrophic rates: an ADNI study with n=1368 MRI scansAPOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 yearsDysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics.Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.Neuroimaging predictors of brain amyloidosis in mild cognitive impairment.The default mode network and related right hemisphere structures may be the key substrates of dementiaAn engineering view on megatrends in radiology: digitization to quantitative tools of medicine.The default mode network may be the key substrate of depressive symptom-related cognitive changes.Dysexecutive versus amnestic Alzheimer disease subgroups: analysis of demographic, genetic, and vascular factorsTau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.Genetically-mediated Grey and White Matter Alteration in Normal Elderly Individuals with the CLU-C Allele Gene.Pathomechanisms of atrophy in insular cortex in Alzheimer's disease.Apraxia in mild cognitive impairment and Alzheimer's disease: validity and reliability of the Van Heugten test for apraxia.Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults.Imaging genomics
P2860
Q30744917-D394E750-A10A-4187-9CD8-6032AD15764EQ33595086-E0A64285-6D34-45C9-8CC5-B31E723B5BC9Q33690208-A57B6C47-E9E3-41C2-B1CC-183D2684DE21Q33695094-88FDD37E-41C5-4618-83B4-4EDF04C33C09Q33933382-3689B752-5DA0-43BA-8C7B-D68AFA73A4A8Q34081087-AD370FB3-49FD-4515-870A-0774B9D1F97AQ34226538-7DF6E522-32F9-4978-9532-B22CBC8F1FFDQ34501939-69359F7C-39D4-48FF-B0DB-0341276A462FQ34717865-0A58D224-31B6-418B-8C99-D8D008FC4E74Q35895780-C95832C1-98AB-499A-AD27-E607DA82A907Q36155517-B66018C6-6749-4A64-AEFD-7EFCBED709B1Q36502788-04E3D587-3A7C-49AA-982D-53C341A32C6EQ36662513-7FC88632-223C-4328-B106-B50FD9BFB6D9Q36808283-90B7B184-3501-48DF-8C9D-854DFA1912FBQ37107704-F7E7C9B6-122C-43FC-AB4A-5FFCE93DB95AQ37220632-BDBA7D35-7A92-4C8E-AA27-F53CD8E0107CQ37419532-3F1C0DBD-9816-48AE-A5DF-868358251EF6Q38429584-0C4A93F1-A38F-4A2D-9929-BC18664D0C77Q44433397-4B996DF7-A43E-49D4-9AED-609C1F8FC86FQ48290805-8BDE491A-AAF9-41E7-904A-60B41AA52535Q51025847-ACD2A4CA-A87F-475B-AD9D-262D30EF1D9BQ57268588-44C957B2-B2CB-446A-88E1-68694B2353CF
P2860
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo
@en
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
@nl
type
label
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo
@en
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
@nl
prefLabel
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo
@en
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
@nl
P2093
P2860
P50
P1433
P1476
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo
@en
P2093
F Sabattoli
P E Rasser
P2860
P304
P356
10.1016/J.NEUROIMAGE.2009.01.009
P407
P50
P577
2009-01-21T00:00:00Z